BACKGROUND: Smoking is an important cardiovascular disease risk factor, but the mechanisms linking smoking to blood pressure are poorly understood. METHODS AND RESULTS: Data on 141 317 participants (62 666 never, 40 669 former, 37 982 current smokers) from 23 population-based studies were included in observational and Mendelian randomization meta-analyses of the associations of smoking status and smoking heaviness with systolic and diastolic blood pressure, hypertension, and resting heart rate. For the Mendelian randomization analyses, a genetic variant rs16969968/rs1051730 was used as a proxy for smoking heaviness in current smokers. In observational analyses, current as compared with never smoking was associated with lower systolic blood pressure and diastolic blood pressure and lower hypertension risk, but with higher resting heart rate. In observational analyses among current smokers, 1 cigarette/day higher level of smoking heaviness was associated with higher (0.21 bpm; 95% confidence interval 0.19; 0.24) resting heart rate and slightly higher diastolic blood pressure (0.05 mm Hg; 95% confidence interval 0.02; 0.08) and systolic blood pressure (0.08 mm Hg; 95% confidence interval 0.03; 0.13). However, in Mendelian randomization analyses among current smokers, although each smoking increasing allele of rs16969968/rs1051730 was associated with higher resting heart rate (0.36 bpm/allele; 95% confidence interval 0.18; 0.54), there was no strong association with diastolic blood pressure, systolic blood pressure, or hypertension. This would suggest a 7 bpm higher heart rate in those who smoke 20 cigarettes/day. CONCLUSIONS: This Mendelian randomization meta-analysis supports a causal association of smoking heaviness with higher level of resting heart rate, but not with blood pressure. These findings suggest that part of the cardiovascular risk of smoking may operate through increasing resting heart rate.
BACKGROUND: Smoking is an important cardiovascular disease risk factor, but the mechanisms linking smoking to blood pressure are poorly understood. METHODS AND RESULTS: Data on 141 317 participants (62 666 never, 40 669 former, 37 982 current smokers) from 23 population-based studies were included in observational and Mendelian randomization meta-analyses of the associations of smoking status and smoking heaviness with systolic and diastolic blood pressure, hypertension, and resting heart rate. For the Mendelian randomization analyses, a genetic variant rs16969968/rs1051730 was used as a proxy for smoking heaviness in current smokers. In observational analyses, current as compared with never smoking was associated with lower systolic blood pressure and diastolic blood pressure and lower hypertension risk, but with higher resting heart rate. In observational analyses among current smokers, 1 cigarette/day higher level of smoking heaviness was associated with higher (0.21 bpm; 95% confidence interval 0.19; 0.24) resting heart rate and slightly higher diastolic blood pressure (0.05 mm Hg; 95% confidence interval 0.02; 0.08) and systolic blood pressure (0.08 mm Hg; 95% confidence interval 0.03; 0.13). However, in Mendelian randomization analyses among current smokers, although each smoking increasing allele of rs16969968/rs1051730 was associated with higher resting heart rate (0.36 bpm/allele; 95% confidence interval 0.18; 0.54), there was no strong association with diastolic blood pressure, systolic blood pressure, or hypertension. This would suggest a 7 bpm higher heart rate in those who smoke 20 cigarettes/day. CONCLUSIONS: This Mendelian randomization meta-analysis supports a causal association of smoking heaviness with higher level of resting heart rate, but not with blood pressure. These findings suggest that part of the cardiovascular risk of smoking may operate through increasing resting heart rate.
Authors: Magnus T Jensen; Jacob L Marott; Kristine H Allin; Børge G Nordestgaard; Gorm B Jensen Journal: Eur J Prev Cardiol Date: 2011-04-27 Impact factor: 7.804
Authors: C Legeai; X Jouven; M Tafflet; J F Dartigues; C Helmer; K Ritchie; P Amouyel; C Tzourio; P Ducimetière; J P Empana Journal: Eur J Cardiovasc Prev Rehabil Date: 2011-02-25
Authors: Rachel M Freathy; Gbenga R Kazeem; Richard W Morris; Paul C D Johnson; Lavinia Paternoster; Shah Ebrahim; Andrew T Hattersley; Anita Hill; Aroon D Hingorani; Claus Holst; Barbara J Jefferis; Sofia I I Kring; Vincent Mooser; Sandosh Padmanabhan; Martin Preisig; Susan M Ring; Naveed Sattar; Mark N Upton; Peter Vollenweider; Gerard Waeber; Thorkild I A Sørensen; Timothy M Frayling; Graham Watt; Debbie A Lawlor; Peter H Whincup; Federica Tozzi; George Davey Smith; Marcus Munafò Journal: Int J Epidemiol Date: 2011-05-18 Impact factor: 7.196
Authors: Marcus R Munafò; Maria N Timofeeva; Richard W Morris; David Prieto-Merino; Naveed Sattar; Paul Brennan; Elaine C Johnstone; Caroline Relton; Paul C D Johnson; Donna Walther; Peter H Whincup; Juan P Casas; George R Uhl; Paolo Vineis; Sandosh Padmanabhan; Barbara J Jefferis; Antoinette Amuzu; Elio Riboli; Mark N Upton; Paul Aveyard; Shah Ebrahim; Aroon D Hingorani; Graham Watt; Tom M Palmer; Nicholas J Timpson; George Davey Smith Journal: J Natl Cancer Inst Date: 2012-04-25 Impact factor: 13.506
Authors: Amy E Taylor; Richard W Morris; Meg E Fluharty; Johan H Bjorngaard; Bjørn Olav Åsvold; Maiken E Gabrielsen; Archie Campbell; Riccardo Marioni; Meena Kumari; Jenni Hällfors; Satu Männistö; Pedro Marques-Vidal; Marika Kaakinen; Alana Cavadino; Iris Postmus; Lise Lotte N Husemoen; Tea Skaaby; Tarunveer S Ahluwalia; Jorien L Treur; Gonneke Willemsen; Caroline Dale; S Goya Wannamethee; Jari Lahti; Aarno Palotie; Katri Räikkönen; Aliaksei Kisialiou; Alex McConnachie; Sandosh Padmanabhan; Andrew Wong; Christine Dalgård; Lavinia Paternoster; Yoav Ben-Shlomo; Jessica Tyrrell; John Horwood; David M Fergusson; Martin A Kennedy; Tim Frayling; Ellen A Nohr; Lene Christiansen; Kirsten Ohm Kyvik; Diana Kuh; Graham Watt; Johan Eriksson; Peter H Whincup; Jacqueline M Vink; Dorret I Boomsma; George Davey Smith; Debbie Lawlor; Allan Linneberg; Ian Ford; J Wouter Jukema; Christine Power; Elina Hyppönen; Marjo-Riitta Jarvelin; Martin Preisig; Katja Borodulin; Jaakko Kaprio; Mika Kivimaki; Blair H Smith; Caroline Hayward; Pål R Romundstad; Thorkild I A Sørensen; Marcus R Munafò; Naveed Sattar Journal: PLoS Genet Date: 2014-12-04 Impact factor: 5.917
Authors: A Feinberg; P M Lopez; K Wyka; N Islam; L Seidl; E Drackett; A Mata; J Pinzon; M R Baker; J Lopez; C Trinh-Shevrin; D Shelley; Z Bailey; K A Maybank; L E Thorpe Journal: J Urban Health Date: 2017-08 Impact factor: 3.671
Authors: Pedro L Valenzuela; Pedro Carrera-Bastos; Beatriz G Gálvez; Gema Ruiz-Hurtado; José M Ordovas; Luis M Ruilope; Alejandro Lucia Journal: Nat Rev Cardiol Date: 2020-10-09 Impact factor: 32.419
Authors: Kayla R Zehr; Allison Segovia; Meera Shah; Mary T Walsh-Wilcox; Barbara H Brumbach; Joe R Anderson; Mary K Walker Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2019-04-12 Impact factor: 4.006
Authors: M B Mehboudi; I Nabipour; K Vahdat; H Darabi; A Raeisi; N Mehrdad; R Heshmat; G Shafiee; B Larijani; A Ostovar Journal: J Hum Hypertens Date: 2017-09-07 Impact factor: 3.012
Authors: Kevin P Jensen; Gerald Valentine; Eugenia Buta; Elise E DeVito; Joel Gelernter; Mehmet Sofuoglu Journal: Pharmacol Biochem Behav Date: 2018-08-11 Impact factor: 3.533
Authors: Robert C Kaplan; Pedro L Baldoni; Garrett M Strizich; Eliseo J Pérez-Stable; Nancy L Saccone; Carmen A Peralta; Krista M Perreira; Marc D Gellman; Jessica S Williams-Nguyen; Carlos J Rodriguez; David J Lee; Martha Daviglus; Gregory A Talavera; James P Lash; Jianwen Cai; Nora Franceschini Journal: Am J Hypertens Date: 2021-03-11 Impact factor: 2.689